About this trial
Hospitalized infants with severe bronchopulmonary dysplasia (BPD) and feeding intolerance will be randomized to 2 weeks of continuous gastric feeding or continuous transpyoloric feeding. Subjects will crossover after 2 weeks and receive 4 weeks of each feeding mode. Respiratory status will be assessed to determine the optimal feeding mode for each infant.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients born <32 weeks' gestation
Currently admitted to the Le Bonheur NICU
Grad 2 or 3 BPD (positive pressure or intubated at 36 weeks PMA)
Signs of gastroesophageal reflux, chronic aspiration, or other feeding intolerance.
Disqualifiers
Known gastrointestinal anomalies
Unable to tolerate ≥100mL/kg/day enteral feeding
Congenital anomalies likely to alter feeding techniques
Surgical feeding tube in place or expected within the next 8 weeks
Trial design
Crossover
Treatments tested in this trial
Gastric feeding
Procedure/SurgerySubjects will be fed through a feeding tube that empties into the stomach.
Transpyloric feeding
Procedure/SurgerySubjects will be fed through a feeding tube that passes through the stomach and empties directly into the small intestine.
Treatment groups
Trial outcomes
Primary outcomes
Respiratory Severity Score (RSS)
RSS (the product of mean airway pressure and oxygen fraction) will be calculated before and after each 2-week intervention block.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.